Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Connors

Showing results (31-40 of 302) with videos related to

Pageof 31
Sort By:
Clinical Lymphoma & Myeloma|November 15, 2006
Treatment of diffuse large B-cell lymphoma: a risk-based approachLaurie H Sehn, Joseph M Connors
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2005
Vaccine therapy for non-Hodgkin's lymphoma and other B-cell malignanciesHeather A Leitch, Joseph M Connors
Oncology (Williston Park, N.Y.)|June 7, 2005
Treatment of aggressive non-Hodgkin's lymphoma: a north American perspectiveLaurie H Sehn, Joseph M Connors
Clinical Lymphoma|January 13, 2004
Primary adrenal lymphomaAndrew P Grigg, Joseph M Connors
Hematology/Oncology Clinics of North America|October 3, 2007
New strategies for the treatment of early stages of Hodgkin's lymphomaDavid A Macdonald, Joseph M Connors
The New England Journal of Medicine|April 19, 2018
Brentuximab Vedotin for Stage III or IV Hodgkin's LymphomaJoseph M Connors, John A Radford
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironmentChristian Steidl, Joseph M Connors, Randy D Gascoyne
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
Hodgkin's lymphoma in adolescentsLynda M Foltz, Kevin W Song, Joseph M Connors
Hematology. American Society of Hematology. Education Program|November 26, 2002
Lymphoma of the skinJoseph M Connors, Eric D Hsi, Francine M Foss
Blood|January 7, 2012
Fludarabine and rituximab for relapsed or refractory hairy cell leukemiaAlina S Gerrie, Leslie N Zypchen, Joseph M Connors
Pageof 31

Showing results (31-40 of 302) with videos related to

Sort By:
Pageof 31
Clinical Lymphoma & Myeloma|November 15, 2006
Treatment of diffuse large B-cell lymphoma: a risk-based approachLaurie H Sehn, Joseph M Connors
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2005
Vaccine therapy for non-Hodgkin's lymphoma and other B-cell malignanciesHeather A Leitch, Joseph M Connors
Oncology (Williston Park, N.Y.)|June 7, 2005
Treatment of aggressive non-Hodgkin's lymphoma: a north American perspectiveLaurie H Sehn, Joseph M Connors
Clinical Lymphoma|January 13, 2004
Primary adrenal lymphomaAndrew P Grigg, Joseph M Connors
Hematology/Oncology Clinics of North America|October 3, 2007
New strategies for the treatment of early stages of Hodgkin's lymphomaDavid A Macdonald, Joseph M Connors
The New England Journal of Medicine|April 19, 2018
Brentuximab Vedotin for Stage III or IV Hodgkin's LymphomaJoseph M Connors, John A Radford
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironmentChristian Steidl, Joseph M Connors, Randy D Gascoyne
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
Hodgkin's lymphoma in adolescentsLynda M Foltz, Kevin W Song, Joseph M Connors
Hematology. American Society of Hematology. Education Program|November 26, 2002
Lymphoma of the skinJoseph M Connors, Eric D Hsi, Francine M Foss
Blood|January 7, 2012
Fludarabine and rituximab for relapsed or refractory hairy cell leukemiaAlina S Gerrie, Leslie N Zypchen, Joseph M Connors
Pageof 31